BenzingaSeptember 29, 2026 at 10:44 AM NY28 Days Ago

Invivyd Outlines Accelerated Approval Submission Path with FDA for COVID-19 Antibody

Invivyd reported Phase 3 LIBERTY trial data for VYD2311, showing strong safety and enhanced COVID-19 antibody levels.

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga